BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4382053)

  • 1. Recovery of noradrenaline levels after reserpine compared with the life-span of amine storage granules in rat and rabbit.
    Dahlström A; Häggendal J
    J Pharm Pharmacol; 1966 Nov; 18(11):750-1. PubMed ID: 4382053
    [No Abstract]   [Full Text] [Related]  

  • 2. The depletion and recovery of noradrenaline in the brain and some sympathetically innervated mammalian tissues after tetrabenazine.
    Häggendal J
    J Pharm Pharmacol; 1968 May; 20(5):364-7. PubMed ID: 4385439
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of reserpine on the structure-activity relationships for the inhibition of noradrenaline uptake in adrenergic nerves in rat and rabbit ventricle by phenethylamines.
    Paton DM; Golko DS
    Can J Physiol Pharmacol; 1977 Apr; 55(2):196-205. PubMed ID: 871952
    [No Abstract]   [Full Text] [Related]  

  • 4. Guanethidine uptake and noradrenaline depletion in noradrenaline storage particles of rat heart.
    Maître L; Staehelin M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):399-400. PubMed ID: 4253828
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of treatment with thyroxine on the noradrenaline content of the rabbit heart.
    Lee WC; Lee CY; Yoo CS
    Br J Pharmacol Chemother; 1965 Dec; 25(3):651-7. PubMed ID: 5870453
    [No Abstract]   [Full Text] [Related]  

  • 6. [The digitalis effect and noradrenaline].
    Förster W; Rösler V; Grade K
    Acta Biol Med Ger; 1966; 16(3):309-12. PubMed ID: 5987020
    [No Abstract]   [Full Text] [Related]  

  • 7. The relation between noradrenaline content of rabbit heart muscle and the amount of k-strophanthin needed to produce arrhythmias.
    Angelucci L; Lorentz G; Baldieri M
    J Pharm Pharmacol; 1966 Dec; 18(12):775-82. PubMed ID: 4381660
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification by metaraminol of reserpine action on noradrenaline stores in the rat heart.
    Manara L; Bareggi SR
    Eur J Pharmacol; 1969 Jul; 7(1):115-7. PubMed ID: 5821799
    [No Abstract]   [Full Text] [Related]  

  • 9. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1965 Nov; 150(2):173-83. PubMed ID: 4379176
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitivity to k-strophanthin and myocardial noradrenaline].
    Angelucci L; Lorentz G; Baldieri M
    Boll Soc Ital Biol Sper; 1966 May; 42(9):467-71. PubMed ID: 5942251
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular sensitivity to exogenous adrenaline and myocardial noradrenaline].
    Lorentz G; Angelucci L; Baldieri M
    Boll Soc Ital Biol Sper; 1966 May; 42(9):471-3. PubMed ID: 5942252
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal by amphetamine of the protective effect of bretylium on reserpine-induced depletion of noradrenaline.
    Chang CC
    J Pharm Pharmacol; 1965 Dec; 17(12):818-20. PubMed ID: 4379763
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the uptake, storage and metabolism of (+)- and (-)-noradrenaline.
    Iversen LL; Jarrott B; Simmonds MA
    Br J Pharmacol; 1971 Dec; 43(4):845-55. PubMed ID: 5152031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanethidine uptake and noradrenaline depletion in noradrenaline storage particles of the rat heart.
    Maître L; Staehelin M
    Biochem Pharmacol; 1971 Jun; 20(6):1233-42. PubMed ID: 5118120
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of fluphenazine on tissue noradrenaline concentrations and its interaction with pargyline.
    Azhary RA; Khayyal MT; Saleh S
    Br J Pharmacol; 1975 Apr; 53(4):593-5. PubMed ID: 1148501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the reduced retention of extravesicular noradrenaline in rabbit atria produced by potassium.
    Paton DM; Lauzon PA
    Eur J Pharmacol; 1977 May; 43(1):27-32. PubMed ID: 862662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the ability of desipramine to interfere with reserpine-induced noradrenaline release.
    Manara L; Sestini MG; Algeri S; Garattini S
    J Pharm Pharmacol; 1966 Mar; 18(3):194-5. PubMed ID: 4381219
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention by calcium administration of reserpine action on rat brain noradrenaline stores: a reappraisal.
    Manara L; Cerletti C; Mennini T
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):471-87. PubMed ID: 959653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention of exogenous norepinephrine and recovery of the responses to tyramine and 1,1-dimethyl-4-phenylpiperazinium iodide after reserpine.
    Bhagat B; Bhattacharya IC; Dhalla NS
    J Pharmacol Exp Ther; 1966 Sep; 153(3):434-9. PubMed ID: 5922321
    [No Abstract]   [Full Text] [Related]  

  • 20. Diurnal rhythms in noradrenaline turnover and motility after reserpine and 6-hydroxydopamine.
    Lemmer B; Wenda K
    Pharmacol Biochem Behav; 1979 Mar; 10(3):361-8. PubMed ID: 572061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.